Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biolase Inc (BIOL)

Biolase Inc (BIOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,448
  • Shares Outstanding, K 21,914
  • Annual Sales, $ 46,160 K
  • Annual Income, $ -21,520 K
  • 60-Month Beta 2.18
  • Price/Sales 0.49
  • Price/Cash Flow N/A
  • Price/Book 5.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +22.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.92 +16.14%
on 08/30/19
1.46 -26.71%
on 08/14/19
-0.39 (-26.71%)
since 08/13/19
3-Month
0.92 +16.14%
on 08/30/19
2.07 -48.37%
on 07/08/19
-0.50 (-31.85%)
since 06/13/19
52-Week
0.91 +17.58%
on 12/17/18
2.87 -62.72%
on 03/07/19
-1.02 (-48.80%)
since 09/13/18

Most Recent Stories

More News
BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate at the 4th Annual Dougherty & Company Institutional Investor Conference being held September...

BIOL : 1.07 (+3.88%)
Biolase: 2Q Earnings Snapshot

IRVINE, Calif. (AP) _ Biolase Inc. (BIOL) on Thursday reported a loss of $3.9 million in its second quarter.

BIOL : 1.07 (+3.88%)
BIOLASE Reports Second Quarter 2019 Results

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported net revenue of $8.7 million for the second quarter ended June 30, 2019, a decrease of 29% compared to the second quarter...

BIOL : 1.07 (+3.88%)
BIOLASE, Inc. to Report Second Quarter 2019 Results on August 8, 2019

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2019 financial and operating results on Thursday, August 8, 2019 after the close of...

BIOL : 1.07 (+3.88%)
Here's Why You Should Invest in Wright Medical Stock Now

Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.

WMGI : 20.90 (-2.93%)
OXFD : 14.01 (+2.64%)
BIOL : 1.07 (+3.88%)
HAE : 125.26 (-0.49%)
Will MedTech Ease Investors' Concern & Outperform? 4 Picks

Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.

OFIX : 50.99 (-1.73%)
BIOL : 1.07 (+3.88%)
RHHBY : 34.4900 (+1.71%)
HAE : 125.26 (-0.49%)
DXCM : 146.26 (-0.61%)
BIOLASE to Present at 9th Annual LD Micro Invitational Investor Conference

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and CEO Todd Norbe and Executive Vice President and CFO John Beaver are scheduled to present at the 9th...

BIOL : 1.07 (+3.88%)
BIOLASE Announces Advancing Dentistry Symposium

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, is proud to announce that it will host the Advancing Dentistry Symposium in San Diego, California on October 18-19, 2019. The conference...

BIOL : 1.07 (+3.88%)
Laser Therapy Market Top Trends, Major Players, Type, Application, Share Analysis, Restraints, Industry Demand, Dynamics, Drivers and Forecast between 2019 to 2023

VRX.TO : 30.80 (-3.33%)
BIOL : 1.07 (+3.88%)
ELOS : 11.00 (unch)
Biolase: 1Q Earnings Snapshot

IRVINE, Calif. (AP) _ Biolase Inc. (BIOL) on Thursday reported a loss of $4.9 million in its first quarter.

BIOL : 1.07 (+3.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BIOL with:

Business Summary

Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent...

See More

Key Turning Points

2nd Resistance Point 1.14
1st Resistance Point 1.11
Last Price 1.07
1st Support Level 1.03
2nd Support Level 0.98

See More

52-Week High 2.87
Fibonacci 61.8% 2.12
Fibonacci 50% 1.89
Fibonacci 38.2% 1.66
Last Price 1.07
52-Week Low 0.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar